Featured 13F manager
Egerton Capital (UK) LLP John Armitage
London, X0 23 processed 13Fs on this site · 2021 Q3–2026 Q2
- $10.4B
- 23 Positions
- 2026 Q2
- +14.9% QoQ
- Top 5 49.3%
Portfolio
top 5 49.3% · top 10 76.0%
- V - VISA · CL A 14.1%
- GOOG - Alphabet · CL C 11.2%
- APH - Amphenol · CL A 8.3%
- AMZN - Amazon 8.2%
- MCO - Moodys 7.5%
- NVDA - Nvidia 6.6%
- MDLN - Medline · CL A 6.3%
- VMC - Vulcan Matls 5.6%
- CRH - CRH PLC 4.5%
- AMAT - Applied Matls 3.7%
- IBKR - Interactive Brokers · CL A 3.5%
- DVN - Devon Energy 3.0%
- Other 17.5%
AUM over time
Book
| MSFT - Microsoft | 7.47% | Add +15.5% | 1,720,051 | $430.30 | $740M | +230,587 | +$74M |
| PGR - Progressive | 7.23% | Add +83.2% | 2,823,894 | $253.76 | $717M | +1,282,516 | +$396M |
| CP - Canadian Pacific | 6.78% | Reduce −15.0% | 7,855,661 | $85.54 | $672M | −1,380,900 | −$55M |
| META - Meta Platforms · CL A | 5.94% | Reduce −23.2% | 1,028,489 | $572.44 | $589M | −311,176 | −$87M |
| AMZN - Amazon | 5.77% | Reduce −21.2% | 3,068,090 | $186.33 | $572M | −827,315 | −$181M |
| GOOG - Alphabet · CL C | 5.51% | Add +0.7% | 3,264,022 | $167.19 | $546M | +23,111 | −$49M |
| GEHC - GE HealthCare | 5.38% | Reduce −22.8% | 5,680,021 | $93.85 | $533M | −1,677,864 | −$40M |
| RNR - Renaissancere | 5.21% | Add +1.9% | 1,894,412 | $272.40 | $516M | +34,486 | +$100M |
| IBKR - Interactive Brokers · CL A | 4.76% | Add +8.0% | 3,382,513 | $139.36 | $471M | +249,143 | +$87M |
| FISV - Fiserv | 4.67% | Reduce −5.8% | 2,578,485 | $179.65 | $463M | −158,255 | +$55M |
| FCNCA - First Ctzns Bancshares · CL A | 4.62% | Reduce −12.2% | 248,807 | $1,841 | $458M | −34,421 | −$19M |
| FLUT - Flutter Entmt | 4.35% | Add +74.4% | 1,815,550 | $237.28 | $431M | +774,266 | +$241M |
| CRH - CRH PLC | 4.13% | Add +12.1% | 4,415,658 | $92.74 | $410M | +475,305 | +$114M |
| GE - GE Aerospace | 3.72% | Reduce −17.5% | 1,956,819 | $188.58 | $369M | −416,456 | −$8M |
| ACGL - Arch Cap Group | 3.58% | Reduce −1.9% | 3,171,222 | $111.88 | $355M | −62,158 | +$29M |
| V - VISA · CL A | 3.27% | Reduce −53.8% | 1,180,075 | $274.95 | $324M | −1,374,073 | −$346M |
| MA - Mastercard · CL A | 3.16% | Add +50.2% | 634,704 | $493.80 | $313M | +212,131 | +$127M |
| BKNG - Booking | 2.73% | Reduce −42.1% | 64,312 | $4,212 | $271M | −46,815 | −$169M |
| UBER - UBER Technologies | 2.56% | Add +89.4% | 3,380,958 | $75.16 | $254M | +1,595,839 | +$124M |
| GEV - GE Vernova | 1.54% | Reduce −23.8% | 597,858 | $254.98 | $152M | −186,650 | +$18M |
| ERJ - Embraer S a | 1.32% | New | 3,707,524 | $35.37 | $131M | +3,707,524 | +$131M |
| IBN - Icici Bank | 1.19% | Reduce −28.5% | 3,963,625 | $29.85 | $118M | −1,577,354 | −$41M |
| MLM - Martin Marietta Matls | 1.11% | New | 204,674 | $538.25 | $110M | +204,674 | +$110M |
| HLT - Hilton | 0.94% | Reduce −17.9% | 405,318 | $230.50 | $93M | −88,231 | −$14M |
| FSLR - First Solar | 0.88% | Reduce −51.0% | 348,161 | $249.44 | $87M | −361,677 | −$73M |
| VRTX - Vertex Pharmaceuticals | 0.58% | New | 124,045 | $465.08 | $58M | +124,045 | +$58M |
| AAPL - Apple | 0.47% | New | 201,738 | $233.00 | $47M | +201,738 | +$47M |
| ARMK - Aramark | 0.46% | New | 1,182,142 | $38.73 | $46M | +1,182,142 | +$46M |
| CB - Chubb | 0.43% | New | 148,764 | $288.39 | $43M | +148,764 | +$43M |
| SN - Sharkninja | 0.19% | Reduce −73.0% | 177,193 | $108.71 | $19M | −479,854 | −$30M |
Exits / last held
not current holdings · last reported size, unchanged · gone vs 2024 Q2
| Stock | % of portfolio | Recent activity | Shares | Reported price* | Value | Share change | $ change |
|---|---|---|---|---|---|---|---|
| CNI - Canadian Natl Ry | 4.85% | Exit | 0 | $118.13 | $480M | −4,066,666 | −$480M |
| CVE - Cenovus Energy | 2.05% | Exit | 0 | $19.66 | $203M | −10,322,992 | −$203M |
Filings history
20 periods · normalized AUM · open a period for holdings
| Period | Holdings | AUM | QoQ | Form | Filed | Filing ID |
|---|---|---|---|---|---|---|
| 2026 Q2 | 23 | $10.4B | +14.9% | 13F-HR | 7/21/2026 | 000158181126000007 |
| 2026 Q1 | 24 | $9B | −2.1% | 13F-HR | 5/13/2026 | 000158181126000005 |
| 2025 Q4 | 23 | $9.2B | −3.0% | 13F-HR | 2/11/2026 | 000158181126000002 |
| 2025 Q3 | 24 | $9.5B | −2.7% | 13F-HR | 11/12/2025 | 000158181125000010 |
| 2025 Q2 | 25 | $9.7B | +12.5% | 13F-HR | 8/12/2025 | 000158181125000007 |
| 2025 Q1 | 27 | $8.7B | +0.2% | 13F-HR | 5/6/2025 | 000158181125000005 |
| 2024 Q4 | 30 | $8.6B | −12.7% | 13F-HR | 2/10/2025 | 000158181125000004 |
| 2024 Q3 | 30 | $9.9B | +0.1% | 13F-HR | 11/5/2024 | 000158181124000009 |
| 2024 Q2 | 26 | $9.9B | −4.3% | 13F-HR | 8/13/2024 | 000158181124000007 |
| 2024 Q1 | 22 | $10.3B | +12.1% | 13F-HR | 5/13/2024 | 000158181124000004 |
| 2023 Q4 | 22 | $9.2B | +7.1% | 13F-HR | 2/12/2024 | 000158181124000003 |
| 2023 Q3 | 22 | $8.6B | −11.2% | 13F-HR | 11/13/2023 | 000158181123000006 |
| 2023 Q2 | 23 | $9.7B | +4.7% | 13F-HR | 8/10/2023 | 000158181123000005 |
| 2023 Q1 | 25 | $9.3B | −20.3% | 13F-HR | 5/9/2023 | 000158181123000004 |
| 2022 Q4 | 21 | $11.6B | −9.8% | 13F-HR | 2/7/2023 | 000158181123000002 |
| 2022 Q3 | 23 | $12.9B | −13.1% | 13F-HR | 11/10/2022 | 000158181122000008 |
| 2022 Q2 | 26 | $14.8B | −21.9% | 13F-HR | 8/9/2022 | 000158181122000007 |
| 2022 Q1 | 29 | $19B | — | RESTATEMENT | 8/3/2022 | 000091957422004541 |
| 2022 Q1 | 29 | $19B | −11.5% | 13F-HR | 5/9/2022 | 000158181122000004 |
| 2021 Q4 | 32 | $21.4B | — | RESTATEMENT | 8/3/2022 | 000091957422004539 |
| 2021 Q4 | 32 | $21.4B | +1.9% | 13F-HR | 2/11/2022 | 000158181122000003 |
| 2021 Q3 | 34 | $21B | — | RESTATEMENT | 8/3/2022 | 000091957422004537 |
| 2021 Q3 | 34 | $21B | — | 13F-HR | 11/8/2021 | 000158181121000007 |
About
Egerton Capital (UK) LLP
23 processed 13Fs on this site · 2021 Q3–2026 Q2